BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 16393210)

  • 1. Barrett's esophagus-is it bad for your health?
    Falk GW
    Am J Gastroenterol; 2005 Dec; 100(12):2622-3. PubMed ID: 16393210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance in Barrett's oesophagus: will a strategy focused on a high-risk group reduce mortality from oesophageal adenocarcinoma?
    Quera R; O'Sullivan K; Quigley EM
    Endoscopy; 2006 Feb; 38(2):162-9. PubMed ID: 16479424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Barrett's esophagus with high-grade dysplasia.
    McAllaster JD; Buckles D; Al-Kasspooles M
    Expert Rev Anticancer Ther; 2009 Mar; 9(3):303-16. PubMed ID: 19275509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal metaplasia is the probable common precursor of adenocarcinoma in Barrett's esophagus and adenocarcinoma of the gastrica cardia.
    Conio M; Cameron AJ
    Gastrointest Endosc; 2001 Dec; 54(6):799-801. PubMed ID: 11762326
    [No Abstract]   [Full Text] [Related]  

  • 5. Barrett's esophagus.
    Falk GW
    Gastrointest Endosc Clin N Am; 1994 Oct; 4(4):773-89. PubMed ID: 7812646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Barrett's esophagus with dysplasia.
    Hagen JA
    Semin Thorac Cardiovasc Surg; 1997 Jul; 9(3):285-9. PubMed ID: 9263347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does Barrett's esophagus respond to chemoradiation therapy for adenocarcinoma of the esophagus?
    Barthel JS; Kucera ST; Lin JL; Hoffe SE; Strosberg JR; Ahmed I; Dilling TJ; Stevens CW
    Gastrointest Endosc; 2010 Feb; 71(2):235-40. PubMed ID: 20003971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality associated with Barrett's esophagus and gastroesophageal reflux disease diagnoses-a population-based cohort study.
    Solaymani-Dodaran M; Logan RF; West J; Card T
    Am J Gastroenterol; 2005 Dec; 100(12):2616-21. PubMed ID: 16393209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux.
    Agarwal B; Swisher SG; Ajani J; Kelly K; Komaki RR; Abu-Hamda E; Correa AM; Roth JA
    Ann Thorac Surg; 2005 May; 79(5):1716-23. PubMed ID: 15854962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
    Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barrett's oesophagus: diagnosis and management.
    Spechler SJ
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Oct; 14(5):857-79. PubMed ID: 11003814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of the patient with Barrett's esophagus: a continuing dilemma for the clinician.
    Katz PO
    Rev Gastroenterol Disord; 2004; 4(2):49-59. PubMed ID: 15184824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barrett's esophagus and esophageal cancer.
    Streitz JM
    Chest Surg Clin N Am; 1994 May; 4(2):227-40. PubMed ID: 8049993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and clinical significance of the AgNOR and PCNA in Barrett's adenocarcinoma and its precancerous lesions].
    Li H; Yao S; Stuart R
    Zhonghua Zhong Liu Za Zhi; 1995 Jul; 17(4):286-8. PubMed ID: 7587897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
    Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer risk in Barrett's oesophagus.
    Dias Pereira A; Suspiro A; Chaves P
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):915-8. PubMed ID: 18049157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barrett's esophagus surveillance: When, how often, does it work?
    Katona BW; Falk GW
    Gastrointest Endosc Clin N Am; 2011 Jan; 21(1):9-24. PubMed ID: 21112494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular biology of esophageal adenocarcinoma.
    Koppert LB; Wijnhoven BP; van Dekken H; Tilanus HW; Dinjens WN
    J Surg Oncol; 2005 Dec; 92(3):169-90. PubMed ID: 16299787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical outline of Barrett's esophagus].
    Kuwano H; Sohda M; Kato H; Miyazaki T; Kimura H
    Nihon Rinsho; 2005 Aug; 63(8):1372-8. PubMed ID: 16101224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barrett's esophagus and cancer risk: a more realistic estimate.
    Rajendra S; Sharma P
    Semin Thorac Cardiovasc Surg; 2011; 23(4):261-2. PubMed ID: 22443641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.